Puig Josep, Remollo Sebastià, Rodríguez-Caamaño Isabel, Castaño Carlos, Comas-Cufí Marc, Werner Mariano, Dolz Guillem, Blasco Jordi, SanRoman Luis, Sanchis Juan Manuel, Aparici-Robles Fernando, González Eva, Fondevila Jon, Vega Pedro, Murias Eduardo, Jiménez Elvira, Oteros Rafael, López-Frias Alfonso, Moreu Manuel, Bashir Saima, Silva Yolanda, Ripoll Enric, Martínez-Fernández Javier, Aguilar Yeray, Méndez José, Sánchez Fernando, de Paco Gonzalo, Flores Alan, Llibre Juan Carlos, Brinjikji Waleed
Radiology Department CDI, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain.
Department of Interventional Neuroradiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
J Neuroimaging. 2025 May-Jun;35(3):e70046. doi: 10.1111/jon.70046.
Large-bore aspiration catheters (LBACs) are used for thrombectomy in large vessel occlusion (LVO), either as a standalone direct aspiration first-pass technique or combined with a stent retriever (ASR). LBAC design may influence ASR thrombectomy efficacy. We compared the safety and performance of the novel MIVI Q segmental catheter with the well-established SOFIA aspiration device in ASR thrombectomy.
We analyzed data from the Registry cOmbined vS SinglE Thrombectomy TechnIques registry of consecutive patients with anterior circulation LVO and compared the outcomes of those treated with first-line ASR thrombectomy using Q (Q5 or Q6) or SOFIA (5F or 6F Plus) catheters. Demographic, clinical, angiographic, and clinical outcome data (24-h National Institute of Health Stroke Scale [NIHSS] and modified Rankin Scale score at 3 months) were compared.
Of the 853 patients, 155 (18.2%) were treated with MIVI Q and 698 (81.8%) with SOFIA catheters. After adjusting for age, sex, NIHSS score at baseline, tPA use, site occlusion, anesthesia type, and diameter and length of SR, the MIVI Q group was comparable to the SOFIA group in terms of first-pass effect or successful final recanalization and safety. However, the MIVI Q group had a shorter mechanical thrombectomy time (20 [10-45] min vs. 33 [20-51] min; odds ratio [OR] = 7.4, 95% confidence interval [CI]: 1.1-14; p = 0.021) and a lower rate of symptomatic intracerebral hemorrhage (3.3% vs. 8.8%; OR = 3.59, 95% CI: 1.45-10.9; p = 0.011).
In ASR neurothrombectomy, SOFIA aspiration catheters were not superior to MIVI Q in achieving successful and complete first-passage recanalization; however, MIVI Q had shorter procedural times and a lower rate of symptomatic intracranial hemorrhage.
大口径抽吸导管(LBACs)用于大血管闭塞(LVO)的血栓切除术,可作为单独的直接抽吸首次通过技术,或与支架取栓器(ASR)联合使用。LBAC的设计可能会影响ASR血栓切除术的疗效。我们比较了新型MIVI Q节段导管与成熟的SOFIA抽吸装置在ASR血栓切除术中的安全性和性能。
我们分析了连续的前循环LVO患者的联合血管内取栓技术登记处的数据,并比较了使用Q(Q5或Q6)或SOFIA(5F或6F Plus)导管进行一线ASR血栓切除术患者的结局。比较了人口统计学、临床、血管造影和临床结局数据(24小时美国国立卫生研究院卒中量表[NIHSS]和3个月时的改良Rankin量表评分)。
853例患者中,155例(18.2%)使用MIVI Q导管治疗,698例(81.8%)使用SOFIA导管治疗。在调整年龄、性别、基线NIHSS评分、tPA使用、闭塞部位、麻醉类型以及SR的直径和长度后,MIVI Q组在首次通过效果或最终成功再通及安全性方面与SOFIA组相当。然而,MIVI Q组的机械血栓切除时间较短(20[10 - 45]分钟对33[20 - 51]分钟;优势比[OR]=7.4,95%置信区间[CI]:1.1 - 14;p = 0.021),且症状性脑出血发生率较低(3.3%对8.8%;OR = 3.59,95% CI:1.45 - 10.9;p = 0.011)。
在ASR神经血栓切除术中,SOFIA抽吸导管在实现成功和完全的首次通过再通方面并不优于MIVI Q;然而,MIVI Q的手术时间更短,症状性颅内出血发生率更低。